Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Focal adhesions are where the cell attaches to it's substrate, whether a blood vessel or the basement membrane. The focal contacts are shown in green, the connections to other cells in blue and actin in red.
A Scientific Interpretation of Stock and Clinical Trial Data that's easy to understand
Check out Whatisthatdrug.com--new posts daily on drugs advertised in current media
Focal Adhesions: How cells crawl along
Focal adhesions are where the cell attaches to it's substrate, whether a blood vessel or the basement membrane. The focal contacts are shown in green, the connections to other cells in blue and actin in red.
About Me
- Science Food Logic
- I have wet bench research experience in pharmacology, biochemistry and cell biology. Further, I have clinical research experience in ophthalmology, pathology and immunology. I am employed full time as a research scientist in the pharmaceutical industry. In my off time, I enjoy creating fine dining dishes as well as 20 minute meals that taste like fine dining. I like to teach both professionally and in the kitchen.
Blog Archive
-
▼
2006
(300)
-
▼
September
(77)
- VIVUS Announces Results Of ALISTA Phase 2b Study; ...
- Dow turns best third quarter in 11 years!
- Alvine Aims at Celiac Disease: Keeping an eye on t...
- Corcept Therapeutics Inc. Announces Negative Resul...
- Threshold Pharmaceuticals Gets Orphan Drug Status-...
- Tokyo and Sydney advance overnight
- Today's picture: Calcium Waves
- FDA Approves Amgen Vectibix to treat Metastatic Co...
- BioCryst Shares Rise on Bird Flu Study: Positive P...
- Pro Pharma shooting up today 38%!
- Picture of the Day: Mitosis
- Big Time Action!! Asian markets rally from US data
- An Update from a Previous Post: Genentech Adds Bra...
- Millennium Pharma to acquire AnorMed---AnorMed sha...
- Interesting Diagram of Prions
- CytRX shares fall on Phase II arimoclomol results
- Phase III data from Acorda sends stock soaring!
- Pro-Pharma updates product pipeline: It's the SUGARS!
- Tuesday word of the day: Focal Adhesion
- A Picture of Microtubules to see what the drug doe...
- EpiCept: Myriad triggers milestone payment for Azi...
- Pharmion, GPC Biotech Shares Soar on Positive late...
- Boston Life Sciences, Inc. Announces Findings from...
- Gardasil is made to the capsid proteins of HPV
- Busy Day with my own research today...
- How Gardasil works post coming soon... I think it'...
- Merck obtains License to Market Gardasil in Europe
- EPIX depressed about phase III trial failure. Shar...
- Word of the day, Friday: Neopterin
- Alcon, Inc.'s TRAVATAN(R) Z Solution Approved By F...
- Medivation Shares Soar on Study Results
- Amgen's phase II results of denosumab encouraging
- Looks like I would have lost that wager,
- Asian markets lower after Thai military coup
- Phase III GlaxoSmith-Kline Results: Boniva users S...
- Merck Moves forward with Vioxx Successor--Arcoxia
- Breaking Cancer News: Patent in Imclone Case Is Is...
- Tuesday's Word: Coup
- Monday: Word of the Day.....Methylation
- Gemin X Biotechnologies Initiates Phase 2 Clinical...
- Generex Biotechnology Announces U.S. Distribution ...
- Phase III Study Initiated for Genmab's EGF Antibody
- Schering-Plough CEO Cures Host of Ills
- Word of the Day, Saturday: Pubmed
- Common Sense: Most Money Is Made By Waiting, Not T...
- Lesson of the day: Friday
- Critical Therapeutics Drug Data Weak: Read here to...
- BioTech vs. Academia: Why can't we get along?
- Apotex deal shows impact of generics on Pharma
- Thursday word of the day: Efficacy
- An explanation of Campath from Genzyme
- Merck Challenged about validity of Vioxx Clinical ...
- Wednesday Word of the day: Pharmacokinetics
- Cardiome shares drop on heart drug test data
- Stratagene Highlights Results of FDA's MicroArray ...
- Labopharm announces Stage III success of Tramadol,...
- ALS-357 Phase I/II Initiated by Advanced Life Scie...
- Term of the Day: Biacore
- Term of the day: Transcription Factor
- Oscient Shares Rise Despite Safety Issues
- Cipher Pharma's Tramadol Fails Phase III, Stock do...
- Genentech Receives FDA Letter for More Data on Pro...
- FDA Advises Aspirin Users That Ibuprofen Can Limit...
- Word of the Day: Oncogene(s)
- Barr (BRL : Barr Labora...
- Term of the day: Tyrosine Kinase
- Word of the Day: Microarray
- Dynavax/AstraZeneca Form Alliance to Develop TLR D...
- Asian Markets Up on Friday Trading..
- Tumor Survey--Cancer Genes Cataloged.
- Genomic Health, Inc. Stock up 18% today
- An Update on Genta, Inc.
- Asian Markets down in thursday trading...
- A Brief Review of Clinical Trials: What do the Dif...
- Shares of drug developer Genta Inc. dropped sharpl...
- US Market News 9-05-06
- Mission Statement to the forum....
-
▼
September
(77)
No comments:
Post a Comment